1. Home
  2. FMS vs ALGN Comparison

FMS vs ALGN Comparison

Compare FMS & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresenius Medical Care AG

FMS

Fresenius Medical Care AG

HOLD

Current Price

$23.27

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Logo Align Technology Inc.

ALGN

Align Technology Inc.

HOLD

Current Price

$157.47

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMS
ALGN
Founded
1996
1997
Country
Germany
United States
Employees
N/A
N/A
Industry
Misc Health and Biotechnology Services
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.1B
10.2B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
FMS
ALGN
Price
$23.27
$157.47
Analyst Decision
Sell
Buy
Analyst Count
2
13
Target Price
$30.00
$190.50
AVG Volume (30 Days)
482.1K
1.6M
Earning Date
11-04-2025
10-29-2025
Dividend Yield
2.45%
N/A
EPS Growth
8.62
N/A
EPS
2.86
5.16
Revenue
$23,046,819,198.00
$3,982,622,000.00
Revenue This Year
$2.12
$2.58
Revenue Next Year
$2.92
$3.41
P/E Ratio
$15.86
$30.45
Revenue Growth
2.10
0.56
52 Week Low
$22.05
$122.00
52 Week High
$30.46
$246.19

Technical Indicators

Market Signals
Indicator
FMS
ALGN
Relative Strength Index (RSI) 37.10 73.38
Support Level $22.51 $144.00
Resistance Level $24.20 $152.99
Average True Range (ATR) 0.30 4.97
MACD 0.09 1.74
Stochastic Oscillator 45.27 92.40

Price Performance

Historical Comparison
FMS
ALGN

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

About ALGN Align Technology Inc.

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Share on Social Networks: